These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 17059910

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N.
    Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369
    [Abstract] [Full Text] [Related]

  • 63. Gout spherules.
    Rim PC, Rossman MG, Roebuck JD.
    J Clin Rheumatol; 2011 Apr 15; 17(3):163. PubMed ID: 21464674
    [No Abstract] [Full Text] [Related]

  • 64. [EFFECT ON URICEMIA, URICOSURIA AND URIC ACID CLEARANCE OF THE ADMINISTRATION OF 2-ACETYLAMINO-5-CHLOROBENZOXAZOLE TO 47 GOUTY PATIENTS].
    MUGLER A.
    Rev Rhum Mal Osteoartic; 1963 Jun 15; 30():363-9. PubMed ID: 14070099
    [No Abstract] [Full Text] [Related]

  • 65. We can make gout management more successful now.
    Becker MA, Chohan S.
    Curr Opin Rheumatol; 2008 Mar 15; 20(2):167-72. PubMed ID: 18349746
    [Abstract] [Full Text] [Related]

  • 66. [Treatment of angina pectoris accompanied by hyperuricemia using Ketazon Spofa and diet].
    Sitar J.
    Vnitr Lek; 1966 Jan 15; 12(1):67-73. PubMed ID: 5930613
    [No Abstract] [Full Text] [Related]

  • 67. Case 6: maintenance therapy for simple intermittent gout.
    Edwards NL.
    Am J Med; 2006 Nov 15; 119(11 Suppl 1):S20-2. PubMed ID: 17059908
    [No Abstract] [Full Text] [Related]

  • 68. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent.
    YU TF, PATON BC, CHENKIN T, BURNS JJ, BRODIE BB, GUTMAN AB.
    J Clin Invest; 1956 Apr 15; 35(4):374-85. PubMed ID: 13306779
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. An in vivo and in vitro potential of Indian ayurvedic herbal formulation Triphala on experimental gouty arthritis in mice.
    Sabina EP, Rasool M.
    Vascul Pharmacol; 2008 Jan 15; 48(1):14-20. PubMed ID: 18065272
    [Abstract] [Full Text] [Related]

  • 75. Allopurinol dosing in renal impairment: walking the tightrope between adequate urate lowering and adverse events.
    Dalbeth N, Stamp L.
    Semin Dial; 2007 Jan 15; 20(5):391-5. PubMed ID: 17897242
    [Abstract] [Full Text] [Related]

  • 76. [Present state of the uric-eliminating treatment of chronic gout].
    Fernández del Vallado, Gijon Baños J, García Soro JM.
    Rev Esp Reum Enferm Osteoartic; 1965 Jan 15; 11(1):33-40. PubMed ID: 5832085
    [No Abstract] [Full Text] [Related]

  • 77. [Combined long-term treatment of gout].
    Müller G.
    Med Welt; 1967 Oct 07; 40():2386-8. PubMed ID: 5605797
    [No Abstract] [Full Text] [Related]

  • 78. [Why anti-gout agents when patients with gouty arthritis are to be surgically treated].
    Hørslev-Petersen K.
    Ugeskr Laeger; 1998 Apr 06; 160(15):2233. PubMed ID: 9599516
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. [Effect of benziodarone on the renal excretion of uric acid].
    Podevin R, Paillard F, Amiel C, Richet G.
    Rev Fr Etud Clin Biol; 1967 Apr 06; 12(4):361-7. PubMed ID: 6051917
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.